LAMEA Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Clinical Nutrition Market
Market Report Description
The Latin America, Middle East and Africa Clinical Nutrition Market would witness market growth of 7.9% CAGR during the forecast period (2020-2026). Dietary therapy is critical to proper growth and development, the prevention of acute complications, and/or the prevention of long-term complications of a given disorder. Failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for people with hereditary metabolic disorders is life-long. The treatment of patients with multiple inborn metabolism mistakes includes a multidisciplinary strategy that incorporates diet and medical care.
Brazil's market dominated the region of Latin America due to an increase in the obese population and an increase in the incidence of chronic diseases. The high incidence of preterm births, contributing to a rise in demand for clinical nutrition, would benefit Brazil's market growth. In addition, a strong association with the American Society of Parenteral and Enteral Nutrition is helping to grow the country's clinical nutrition market.
The presence of associations such as the South African Society for Enteral and Parental Nutrition, creating awareness of clinical nutrition in the country, coupled with the increasing burden of disease, will drive the South African market over the forecast timeframe. Health infrastructure creation and growing efforts from both the public and private sectors to improve sales of dietary formulas throughout the country would fuel market growth.
Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
Scope of the LAMEA Clinical Nutrition Market Analysis
By Route of Administration
- Enteral and
- Neurological Diseases
- Gastrointestinal Disorders
- Metabolic Disorders and
- Other Applications
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abbott Laboratories
- Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Nestle S.A.
- Lonza Group AG
- BASF SE
- Ajinomoto Co., Inc.
- Perrigo Company PLC
- Hero Nutritionals, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free